4 Dec 2019 Protagonist Therapeutics insiders bought as PTGX tanked 45% after preliminary drug results were interpreted as negative. The stock bounced is calculated by multiplying the current stock price by the number of shares outstanding. Protagonist Therapeutics market cap as of March 13, 2020 is $0.22B . 16 Dec 2019 This means that over the past quarter there has been an increase of insiders buying their shares of PTGX in relation to earlier this year. IPO Status Public Stock Symbol NASDAQ:PTGX Company Type For Profit. Website www.protagonist-inc.com LinkedIn View on LinkedIn Contact Email 3 Dec 2019 Protagonist Therapeutics Inc. stock (NASDAQ:PTGX) nosedived 47% on Tuesday after the company released preliminary results from its phase 專注於發現及開發以胜肽為基礎的新藥Protagonist Therapeutics, Inc.(PTGX.US) 成立 stock PTGX image. Protagonist Therapeutics. 〈PTGX〉. 基本資料 · 行情 報價 Initiated Coverage by Barclays Capital (Ranked 25th) to Overweight $PTGX # PTGX $PTGX - David Y. Liu Sells 3,500 Shares of Protagonist Therapeutics Inc
Stock screener for investors and traders, financial visualizations.
Get breaking news and analysis on Protagonist Therapeutics, Inc. (PTGX) stock, price quote and chart, trading and investing tools. Stock screener for investors and traders, financial visualizations. investment & stock information. Get the latest Protagonist Therapeutics, Inc. PTGX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Common Stock Shares Outstanding, 27,206,447 shares (as of 2019-09-30) Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has 86 institutional investors and View the latest PTGX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of PROTAGONIST THERAPEUTICS, INC.. Based on 1 Wall Street analysts offering stock ratings for Protagonist Therapeutics in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts. Get today's Protagonist Therapeutics Inc stock price and latest PTGX news as well as Protagonist Therapeutics real-time stock quotes, technical analysis, full
Stock screener for investors and traders, financial visualizations.
investment & stock information. Get the latest Protagonist Therapeutics, Inc. PTGX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Common Stock Shares Outstanding, 27,206,447 shares (as of 2019-09-30) Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has 86 institutional investors and View the latest PTGX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of PROTAGONIST THERAPEUTICS, INC.. Based on 1 Wall Street analysts offering stock ratings for Protagonist Therapeutics in the last 3 months (by analysts ranked 0 to 5 stars). All Analysts.
8 May 2019 and biopharma Protagonist Therapeutics Inc (NASDAQ:PTGX). Below, we will dive into what is moving the shares of WKHS, PM, and PTGX.
專注於發現及開發以胜肽為基礎的新藥Protagonist Therapeutics, Inc.(PTGX.US) 成立 stock PTGX image. Protagonist Therapeutics. 〈PTGX〉. 基本資料 · 行情 報價
Find the latest Protagonist Therapeutics, Inc. (PTGX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Stock quote for Protagonist Therapeutics, Inc. Common Stock Common Stock (PTGX) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Protagonist Therapeutics, Inc. Common Stock (PTGX) Q1 2019 Earnings Call Transcript Motley Fool Transcribing | May 15, 2019 PTGX earnings call for the period ending March 31, 2019.